Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2005 1
2007 1
2009 2
2010 1
2011 2
2012 6
2013 2
2014 3
2015 8
2016 10
2017 14
2018 13
2019 8
2020 8
2021 8
2022 3
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
Ruxolitinib, IV Immunoglobulin, and High-Dose Glucocorticoids for Critically Ill Adults With Secondary Hemophagocytic Lymphohistiocytosis: A Single-Center Observational Pilot Study.
Scholz L, Posch F, Schulz E, Gornicec M, Wölfler A, Reisinger AC, Reinisch A, Eller P, Eisner F, Kreuzer P, Stradner M, Rosenkranz AR, Krammer F, Schilcher G, Krause R, Hatzl S. Scholz L, et al. Among authors: wolfler a. Crit Care Explor. 2024 Feb 2;6(2):e1046. doi: 10.1097/CCE.0000000000001046. eCollection 2024 Feb. Crit Care Explor. 2024. PMID: 38511127 Free PMC article.
ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options.
Kiladjian JJ, Marin FF, Al-Ali HK, Alvarez-Larrán A, Beggiato E, Bieniaszewska M, Breccia M, Buxhofer-Ausch V, Cerna O, Crisan AM, Danaila CD, De Stefano V, Döhner K, Empson V, Gora-Tybor J, Griesshammer M, Grosicki S, Guglielmelli P, García-Gutierrez V, Heidel FH, Illés A, Tomuleasa C, James C, Koschmieder S, Krauth MT, Krejcy K, Lazaroiu MC, Mayer J, Nagy ZG, Nicolini FE, Palandri F, Pappa V, Reiter AJ, Sacha T, Schlager S, Schmidt S, Terpos E, Unger M, Wölfler A, Cirici BX, Klade C. Kiladjian JJ, et al. Among authors: wolfler a. Ann Hematol. 2024 Mar 4. doi: 10.1007/s00277-024-05665-4. Online ahead of print. Ann Hematol. 2024. PMID: 38438627
Incidence of Diabetes Mellitus and Its Impact on Outcomes in Patients Undergoing Surgical Pancreatectomy for Non-Malignant and Malignant Pancreatobiliary Diseases-A Retrospective Analysis.
Schranz A, Sternad C, Aziz F, Wagner D, Kornprat P, Sucher R, Jost PJ, Wölfler A, Pieber TR, Sourij H, Riedl JM, Aberer F. Schranz A, et al. Among authors: wolfler a. J Clin Med. 2023 Dec 6;12(24):7532. doi: 10.3390/jcm12247532. J Clin Med. 2023. PMID: 38137600 Free PMC article.
BRAFV600E promotes DC3/monocyte differentiation in human gene-engineered HSPCs and causes multisystem histiocytosis.
Sconocchia T, Foßelteder J, Auinger L, Özkaya E, Benezeder T, Lang M, Beham-Schmid C, Hoefler G, Zebisch A, Wölfler A, Sill H, Wolf P, Strobl H, Reinisch A. Sconocchia T, et al. Among authors: wolfler a. Leukemia. 2023 Nov;37(11):2292-2296. doi: 10.1038/s41375-023-02019-3. Epub 2023 Sep 6. Leukemia. 2023. PMID: 37673974 Free PMC article. No abstract available.
Human gene-engineered calreticulin mutant stem cells recapitulate MPN hallmarks and identify targetable vulnerabilities.
Foßelteder J, Pabst G, Sconocchia T, Schlacher A, Auinger L, Kashofer K, Beham-Schmid C, Trajanoski S, Waskow C, Schöll W, Sill H, Zebisch A, Wölfler A, Thomas D, Reinisch A. Foßelteder J, et al. Among authors: wolfler a. Leukemia. 2023 Apr;37(4):843-853. doi: 10.1038/s41375-023-01848-6. Epub 2023 Feb 22. Leukemia. 2023. PMID: 36813992 Free PMC article.
Comparison of acute myeloid leukemia and myelodysplastic syndromes with TP53 aberrations.
Dutta S, Moritz J, Pregartner G, Thallinger GG, Brandstätter I, Lind K, Rezania S, Lyssy F, Reinisch A, Zebisch A, Berghold A, Wölfler A, Sill H. Dutta S, et al. Among authors: wolfler a. Ann Hematol. 2022 Apr;101(4):837-846. doi: 10.1007/s00277-022-04766-2. Epub 2022 Jan 26. Ann Hematol. 2022. PMID: 35083527 Free PMC article.
miR-23a mediates resistance to hypomethylating agents in myeloid neoplasms.
Mayer MC, Berg JL, Perfler B, Hatzl S, Herzog SA, Bachmaier G, Berghold A, Reinisch A, Wölfler A, Sill H, Zebisch A. Mayer MC, et al. Among authors: wolfler a. Ann Hematol. 2021 Nov;100(11):2845-2847. doi: 10.1007/s00277-021-04598-6. Epub 2021 Jul 22. Ann Hematol. 2021. PMID: 34291333 No abstract available.
83 results